Brief: Bellus Health to sell subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals

BELLUS Health

16/03/2017 21:00

March 16 (Reuters) - Bellus Health Inc  BLU.TO  
    * Press release - Bellus Health announces the sale of 
subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals 
    * Bellus Health Inc - deal for total consideration of CA$2.7 
million 
    * Bellus Health Inc- in addition will receive a portion of 
certain post-approval revenues related to shigamab program 
    * Bellus Health Inc - "upfront proceeds from this 
transaction also meaningfully extend our cash runway to Q4 2018" 
 
Source text for Eikon:  ID:nCNWrXGMLa  
Further company coverage:  BLU.TO  
 
 ((Bangalore.newsroom@thomsonreuters.com;))